GlassScriptPhysician profile
Gaurav Tyagi
NPI 1306161500
$13,165.91
in general payments reported to CMS, 2019-2025
33 companies · $1,050 in 2025
The $1,050 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $511 · 2021: $1,703 · 2022: $1,658 · 2023: $5,629 · 2024: $1,628 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,265 · Travel and Lodging: $3,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,264.89 |
| Travel and Lodging | $3,042.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $3,290.65 | 2023 | Angiovac |
| Abbott Laboratories | $2,099.23 | 2019-2025 | Aveir, Assurity, Allure Quadra |
| Edwards Lifesciences Corporation | $1,903.02 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $1,716.17 | 2019-2025 | Impella |
| Medtronic, INC. | $1,371.70 | 2021-2025 | Micra, Corevalve Evolut R, Symplicity G3 |
| Medtronic Vascular, INC. | $468.09 | 2019-2020 | |
| Cvrx, INC. | $341.83 | 2021-2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $300.39 | 2019-2021 | |
| Inari Medical, INC. | $223.44 | 2022 | |
| Boston Scientific Corporation | $212.12 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Amgen INC. | $160.16 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $128.65 | 2019-2020 | |
| Novo Nordisk INC | $99.00 | 2020-2025 | Wegovy, Ozempic |
| Merck Sharp & Dohme LLC | $92.08 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.43 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $86.67 | 2020-2022 | |
| Pfizer INC. | $81.16 | 2019-2023 | |
| Philips North America LLC | $74.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $60.78 | 2022-2025 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $60.28 | 2021 | |
| Sanofi-Aventis U.S. LLC | $59.69 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $33.51 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $26.74 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $23.26 | 2021 | |
| Surmodics, INC. | $23.05 | 2023 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Kiniksa Pharmaceuticals, LTD. | $22.76 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $20.75 | 2025 | Savvywire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.60 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $18.85 | 2023 | Inpefa |
| Csl Behring | $17.93 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.02 | 2019 | |
| Bardy Diagnostics, INC. | $13.62 | 2021 | |
| Livanova USA, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Tyagi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.